Pharmacists at Stony Brook have proven instrumental in expediting the introduction of plozasiran, a therapy discussed in a recently published piece. Although the complete details remain behind a paywall, the article underscores the expanding influence of pharmacy professionals in ensuring swift healthcare advancements.